Lupo AM, Lawson AA, Rentea RM, Kapalu CL, Rosen JM. Intravaginal Mesalamine Administration: A Novel Technique for Neovaginal Colitis.
J Pediatr Adolesc Gynecol 2024;
37:93-94. [PMID:
37652182 DOI:
10.1016/j.jpag.2023.08.006]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 08/07/2023] [Accepted: 08/21/2023] [Indexed: 09/02/2023]
Abstract
OBJECTIVE
We aim to present a novel technique for the treatment of neovaginal diversion colitis (also known as neovaginal colitis).
CASE
OT is a 21-year-old cisgender female with a history of VACTERL who underwent a colonic vaginoplasty as an infant. She presented with symptoms indicative of and later diagnosed as neovaginal diversion colitis. The patient underwent a novel regimen of vaginal instillation of mesalamine followed by complete resolution of her symptoms.
DISCUSSION
The following case study demonstrates a potentially effective treatment for cases of neovaginal diversion colitis.
Collapse